Studies on Cannabidiol (CBD) oil have recently been fully licensed in the USA. CBD is found in marijuana and has been shown to help in the treatment of severe epilepsy, depression and anxiety, chronic pain, and skin conditions such as acne, eczema, and dermatitis. Studies are also looking at the role CBD can play as an anti-aging regimen. CBD has been shown to unlock both CB1 and CB2 receptors in the body’s endocannabinoid system (ECS). It is for this reason that it has far-reaching benefits on treating neurological disorders, inflammation, skin conditions, and chronic pain. Unlike the tetrahydrocannabinol (THC) component of marijuana, CBD lacks intoxicating effects that decrease short term memory, impair motor skills, and even lead to paranoia and hallucinatory episodes. Consequently, thanks to its positive effects and its legalization across many states in the U.S., it may be readily available for those who need it in the future.
Nitin Khanna is one of the people leading the charge towards the use of medical marijuana in the world. The current CEO of MergerTech has been a firm believer in the place of CBD within the cannabis industry. He was the CEO of Cura Cannabis, a company he founded in 2015, until 2018. By the time he was leaving this position, he had made the company the leading provider of cannabis oil and vape cartridges in the Northwest.
Born in India, Nitin Khanna immigrated to the U.S. to pursue his undergraduate and masters education in industrial engineering at Purdue University. It was while pursuing his doctoral studies that the entrepreneurship bug bit him leading to the establishment of his first tech company, Saber Corporation. The firm was dedicated to the provision of state government solutions ranging from managing electoral systems, drivers licenses, and unemployment registration, among other solutions. By the time he was selling the company, it was bringing in $300 million in revenues and employing more than 1,500 people.
His second company, MergerTech, was founded in 2009. The company specializes in mergers and acquisitions in the tech industry for companies beneath the $100 million threshold. By connecting U.S.-based tech startups to ideal buyers across the globe, he is helping these companies grow their revenue and customer base. Despite not being actively involved with Cura Cannabis, Nitin Khanna is looking forward to the company dominating the global cannabis industry in the future.
Read more about Nitin in an interview he gave recently https://interview.net/nitin-khanna-interview/